Hangzhou Matrix Medical Technology Co., Ltd. is headquartered in Hangzhou Future Science and Technology City, with production base in both Hangzhou and Anji. We are the first high-tech enterprise in the industry to specialize in intravascular photochemical cross-linking technology.
Guided by the philosophy of “intervention without implantation,” Matrix focuses on the R&D, and manufacturing of innovative medical devices for vascular intervention. Leveraging its proprietary photobiostimulation technology platform, the company is pioneering a Chinese solution for next-generation vascular therapy, with a growing portfolio that includes the Natural Vascular Scaffold (NVS) series, Intracranial PBM series, and Vascular Closure Devices.
In the future, Matrix Medical will take solving clinical pain points as our primary starting point, develop new interventional medical devices, and strive to provide patients with "Chinese original treatment solution". It will actively promote the research and development of innovative technologies and achieve true "interventional without implantation"
Patent application
Proportion of technical personnel
Production base
Proportion of master's and doctoral degrees
Define the infinite possibilities of vascular intervention
Sincerity, Passion, Responsibility
Using Chinese original innovations to benefit patients worldwide,
defining the infinite possibilities of vascular intervention.
Innovation illuminates life
History